The U.S. dollar gained in strength against its peers, recovering after recent weak spells, on safe-haven demand on continued impasse over a fiscal stimulus and on reports showing a surge in coronavirus cases in Europe.
The greenback's gains were also due to news about Johnson & Johnson pausing its final-stage vaccine trial due to the unexplained illness of a participant.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com